Upgrade to
Pro
Toggle navigation
Home
Prices
Returns
News
Ratings
Sectors
Analysis
Annual reports
Insiders
Short
Home
Advice
Beursadvies Beaufort Securities over GlaxoSmithKline
Beaufort Securities advice for GlaxoSmithKline
Date
Bank
Stock
Advice
Price
Difference
February 09, 2018
Beaufort Securities
GlaxoSmithKline
Buy
1310.00 GBP
-33.66 %
Advice details
Op 09 feb herhalen de analisten van Beaufort Securities hun koopadvies voor
het Britse farmaceutisch concern GlaxoSmithKline
(ISIN:
US37733W1053
/ Mnemo:
GSKl
). Het 12-maands koersdoel wordt neerwaarts bijgesteld van 1346.0 GBP naar 1310.0 GBP.
Back
Registrate here for our newsletter
If you are a human, ignore this field
Outlook results
Thursday US publications Ferrellgas Partners LP and Park City Group Inc
Thursday European publications abrdn Property Income Trust Ltd and Enwell Energy PLC
Wednesday US publications H.B. Fuller Company and Migom Global Corp
Tweets door @Valuespectrum
Returns European stocks
Crypto currencies information